19799607 | Expression of thioredoxin during progression of hamster and human cholangiocarcinoma. | Cancer Sci | 2010 Jan | Yoon BI | doi: 10.1111/j.1349-7006.2009.01353.x |
24720336 | Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. | Curr Cancer Drug Targets | 2014 | Li W | - |
14703116 | Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. | Cell Biol Toxicol | 2003 Oct | Kim HJ | - |
25174623 | Thioredoxin 1 as a serum marker for ovarian cancer and its use in combination with CA125 for improving the sensitivity of ovarian cancer diagnoses. | Biomarkers | 2014 Nov | Park BJ | doi: 10.3109/1354750X.2014.956793 |
26334622 | Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients. | Tumour Biol | 2016 Feb | Fan J | doi: 10.1007/s13277-015-3994-x |
24962940 | An investigation into the serum thioredoxin, superoxide dismutase, malondialdehyde, and advanced oxidation protein products in patients with breast cancer. | Ann Surg Oncol | 2014 Dec | Kilic N | doi: 10.1245/s10434-014-3859-3 |
28411237 | Physical interaction between human ribonucleotide reductase large subunit and thioredoxin increases colorectal cancer malignancy. | J Biol Chem | 2017 Jun 2 | Lou M | doi: 10.1074/jbc.M117.783365 |
26460805 | Down-Regulation of Thioredoxin1 Is Involved in Death of Calu-6 Lung Cancer Cells Treated With Suberoyl Bishydroxamic Acid. | J Cell Biochem | 2016 May | You BR | doi: 10.1002/jcb.25409 |
23133653 | Polymorphisms in thioredoxin reductase and selenoprotein K genes and selenium status modulate risk of prostate cancer. | PLoS One | 2012 | M??plan C | doi: 10.1371/journal.pone.0048709 |
19723146 | Expression profiles of thioredoxin family proteins in human lung cancer tissue: correlation with proliferation and differentiation. | Histopathology | 2009 Sep | Fernandes AP | doi: 10.1111/j.1365-2559.2009.03381.x. |
17949784 | Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. | Hum Pathol | 2008 Feb | Noike T | - |
25483731 | Thioredoxin-1 inhibitor, 1-methylpropyl 2-imidazolyl disulfide, inhibits the growth, migration and invasion of colorectal cancer cell lines. | Oncol Rep | 2015 Feb | Wang F | doi: 10.3892/or.2014.3652 |
20955789 | Thioredoxin 1 as a subcellular biomarker of redox imbalance in human prostate cancer progression. | Free Radic Biol Med | 2010 Dec 15 | Shan W | doi: 10.1016/j.freeradbiomed.2010.10.691 |
21963718 | Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. | FEBS Lett | 2011 Oct 20 | Farina AR | doi: 10.1016/j.febslet.2011.09.023 |
23112551 | Thioredoxin and thioredoxin-interacting protein as prognostic markers for gastric cancer recurrence. | World J Gastroenterol | 2012 Oct 21 | Lim JY | doi: 10.3748/wjg.v18.i39.5581. |
12878985 | Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. | J Lab Clin Med | 2003 Jul | Raffel J | - |
12189205 | The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. | Proc Natl Acad Sci U S A | 2002 Sep 3 | Butler LM | - |
19773351 | The cyclin-dependent kinase inhibitor, p21(WAF1), promotes angiogenesis by repressing gene transcription of thioredoxin-binding protein 2 in cancer cells. | Carcinogenesis | 2009 Nov | Kuljaca S | doi: 10.1093/carcin/bgp225 |
28483515 | Thioredoxin-1 promotes colorectal cancer invasion and metastasis through crosstalk with S100P. | Cancer Lett | 2017 Aug 10 | Lin F | doi: 10.1016/j.canlet.2017.04.036 |
29053012 | The ratio of thioredoxin/Keap1 protein level is a predictor of distant metastasis in colorectal cancer. | Biomark Med | 2017 Dec | Chang LC | doi: 10.2217/bmm-2017-0107 |
27779244 | Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy. | Pharmacogenomics J | 2017 Dec | Pontikakis S | doi: 10.1038/tpj.2016.63 |
29089489 | Thioredoxin-1 protects against androgen receptor-induced redox vulnerability in castration-resistant prostate cancer. | Nat Commun | 2017 Oct 31 | Samaranayake GJ | doi: 10.1038/s41467-017-01269-x. |
30911354 | Increased Thioredoxin-1 Expression Promotes Cancer Progression and Predicts Poor Prognosis in Patients with Gastric Cancer. | Oxid Med Cell Longev | 2019 Feb 18 | Shang W | doi: 10.1155/2019/9291683 |